#Health #AI #DrugDiscovery #Biotech #PulmonaryFibrosis #MedicalInnovation #ArtificialIntelligence #Pharma #ClinicalTrials #Healthcare #FutureOfMedicine
https://the-14.com/is-ai-hype-in-drug-development-about-to-turn-into-reality/
In a ground-breaking advance for regenerative medicine, scientists have successfully restored vision by using stem cells to regenerate corneal tissue, the transparent layer that covers the front of the eye. Unlike traditional corneal transplants, which rely on scarce donors and carry a risk of immune rejection, this method uses a patient’s own stem cells to grow new, healthy tissue that integrates seamlessly with the eye.
The results have been extraordinary—patients with severe vision loss, once reliant on donors or resigned to permanent impairment, regained clear sight with minimal complications. Early clinical trials show that the regenerated corneas remain stable over time, offering lasting improvements in vision and quality of life.
Beyond corneal injuries, researchers see enormous potential in extending this approach to other causes of blindness, such as retinal damage and age-related eye diseases. By harnessing the body’s own healing mechanisms, medicine is shifting from replacement therapies to natural renewal, opening the door to a future where blindness can be reversed.
Eye & Vision
#VisionRestoration #EyeHealth #BlindnessCure #VisionResearch #CornealRegeneration #CorneaRepair #SightRecovery #Ophthalmology #EyeCare #RestoringSight
Stem Cells & Regenerative Medicine
#StemCells #RegenerativeMedicine #CellTherapy #TissueEngineering #MedicalBreakthrough #BiomedicalResearch #NextGenMedicine #LifeSciences #HealingWithCells
Medical Innovation & Science
#MedicalInnovation #MedicalResearch #ScienceNews #FutureOfMedicine #HealthTech #ClinicalTrials #HealthInnovation #ScienceIsAwesome
Hope & Awareness
#HopeInScience #HealingThroughScience #EndingBlindness #BetterVision #QualityOfLife
💡 What if we could design clinical trials that deliver results in just 4 years, instead of 10? That's what our INNODIA project achieved in their quest to speed up the development of treatments for #Type1Diabetes
👉 Find out more about the trial in our Q&A with INNODIA coordinator Chantal Mathieu - https://link.europa.eu/F8VGRt
471. That's how many emails were sent by @gregory_ms to inform subscribers of new clinical trials and new research for #MultipleSclerosis. You can get these alerts by subscribing at https://gregory-ms.com/
This can be huge! João Nabais, a master's student, managed to train Llama 2-8B on #ClinicalTrials for breast cancer without any major infrastructure. The details are after the click, with links for his code.
https://brunoamaral.eu/affordable-ai-for-clinical-trials-the-story-of-joao-nabais/
Blickwinkel: Abhängigkeit von US-Datenbanken
Im Deutschen Ärzteblatt schildert Elke Hausner, stellvertretende Leiterin des IQWiG-Ressorts #Informationsmanagement, die Sorgen um #PubMed oder #ClinicalTrials.gov und die Ansprüche an mögliche Alternativen.
https://www.aerzteblatt.de/search/result/3b031a98-3795-4381-8cfa-84d31a8546de?q=iqwig
🚨 Relaunch of CRAN Task View: Clinical Trial Design, Monitoring, and Analysis
#rstats
Complete rewrite by an international team of experts working in #clinicaltrials
Ya Wang, Thomas Jaki, Laura Pascasio Harris, Orla Doyle, Elias Laurin Meyer, Wilmar Igl